Béatrice NAWROCKI-RABY

University Name

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (11)

Collaborators (8)

isabelle hininger-favier

Sylvie Coscoy

Université PSL

Julie Gavard

Claire CALMEL

florence franconi

Université d'Angers

Uwe Schlattner

Université Grenoble Alpes

TERESITA PADILLA-BENAVIDES

Assistant Professor

Wesleyan University

UNITED STATES

Catherine Guette

Université d'Angers

Béatrice NAWROCKI-RABY

Research Interests

Explore related searches

Contact this professor

Articles (11)

Collaborators (8)

isabelle hininger-favier

Sylvie Coscoy

Julie Gavard

Claire CALMEL

florence franconi

Uwe Schlattner

TERESITA PADILLA-BENAVIDES

Catherine Guette

How do I reach out?

Meet Kite AI

Béatrice NAWROCKI-RABY

Research Interests

Explore related searches

Contact this professor

Articles (11)

LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer.

HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies

Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors.

Transcriptomic FHIT<sup>low</sup>/pHER2<sup>high</sup> signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer.

The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor

Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial–Mesenchymal State in Cancer Cells

ZO-1 Intracellular Localization Organizes Immune Response in Non-Small Cell Lung Cancer.

Hypoxia in Lung Cancer Management: A Translational Approach

Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions

S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.

FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.

Collaborators (8)

isabelle hininger-favier

Sylvie Coscoy

Julie Gavard

Claire CALMEL

florence franconi

Uwe Schlattner

TERESITA PADILLA-BENAVIDES

Catherine Guette

How do I reach out?

Meet Kite AI